Nulojix - direct healthcare professional communication (DHPC)

belatacept
DHPCHuman

Slovenian is available via eTranslation, the European Commission's machine translation service.

Translate to Slovenian | Important information about machine translation

O modulu

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Dokumenti

Direct healthcare professional communication (DHPC): Nulojix (belatacept): Risk of medication errors due to change in maintenance dose from 5 mg/kg to 6 mg/kg

English (EN) (238.2 KB - PDF)

Prva objava:
Prikaži

Key facts

Medicine name
Nulojix
Active substance
belatacept
Therapeutic area (MeSH)
  • Graft Rejection
  • Kidney Transplantation
Procedure number
EMEA/H/C/002098/II/0079/G
Regulatory outcome
Maintenance
DHPC type
Medication error
Human ATC codes
L04AA28
Dissemination date

Share this page